Task: Answer the multiple choice question.
Query: Which drug exhibits a 4.374% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Cc1ccc(/C=C/C2=NN(C)C(=O)CC2)cc1
b) CC1(C)CC(=O)C(C(=S)Nc2ccccc2)=C(NC2CC(C)(C)NC(C)(C)C2)C1
c) Cc1cc(C)nc(N2C(=O)CC(Cc3ccc(Cl)cc3)C2=O)n1
Answer: a. Cc1ccc(/C=C/C2=NN(C)C(=O)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(/C=C/C2=NN(C)C(=O)CC2)cc1
Cc1ccc(/C=C/C2=NN(C)C(=O)CC2)cc1
2-methyl-6-[(E)-2-(4-methylphenyl)ethenyl]-4,5-dihydropyridazin-3-one